These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 12394411)

  • 1. Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies.
    Volkow ND; Fowler JS; Wang GJ
    Behav Pharmacol; 2002 Sep; 13(5-6):355-66. PubMed ID: 12394411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans.
    Volkow ND; Fowler JS; Wang GJ
    J Psychopharmacol; 1999 Dec; 13(4):337-45. PubMed ID: 10667609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies.
    Volkow ND; Fowler JS; Wang GJ; Goldstein RZ
    Neurobiol Learn Mem; 2002 Nov; 78(3):610-24. PubMed ID: 12559839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies.
    Volkow ND; Fowler JS; Wang GJ; Ding YS; Gatley SJ
    Eur Neuropsychopharmacol; 2002 Dec; 12(6):557-66. PubMed ID: 12468018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine in drug abuse and addiction: results of imaging studies and treatment implications.
    Volkow ND; Fowler JS; Wang GJ; Swanson JM; Telang F
    Arch Neurol; 2007 Nov; 64(11):1575-9. PubMed ID: 17998440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain DA D2 receptors predict reinforcing effects of stimulants in humans: replication study.
    Volkow ND; Wang GJ; Fowler JS; Thanos PP; Logan J; Gatley SJ; Gifford A; Ding YS; Wong C; Pappas N
    Synapse; 2002 Nov; 46(2):79-82. PubMed ID: 12211085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction.
    Volkow ND; Wang GJ; Fowler JS; Hitzemann R; Angrist B; Gatley SJ; Logan J; Ding YS; Pappas N
    Am J Psychiatry; 1999 Jan; 156(1):19-26. PubMed ID: 9892293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography molecular imaging of dopaminergic system in drug addiction.
    Hou H; Tian M; Zhang H
    Anat Rec (Hoboken); 2012 May; 295(5):722-33. PubMed ID: 22467195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From rats to humans and return: testing addiction hypotheses by combined PET imaging and self-reported measures of psychostimulant effects. Commentary on Volkow et al. 'Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies'.
    Di Chiara G
    Behav Pharmacol; 2002 Sep; 13(5-6):371-7. PubMed ID: 12394413
    [No Abstract]   [Full Text] [Related]  

  • 10. Dopamine in drug abuse and addiction: results from imaging studies and treatment implications.
    Volkow ND; Fowler JS; Wang GJ; Swanson JM
    Mol Psychiatry; 2004 Jun; 9(6):557-69. PubMed ID: 15098002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain.
    Volkow ND; Wang G; Fowler JS; Logan J; Gerasimov M; Maynard L; Ding Y; Gatley SJ; Gifford A; Franceschi D
    J Neurosci; 2001 Jan; 21(2):RC121. PubMed ID: 11160455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD.
    Volkow ND; Swanson JM
    Am J Psychiatry; 2003 Nov; 160(11):1909-18. PubMed ID: 14594733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations.
    Villemagne V; Yuan J; Wong DF; Dannals RF; Hatzidimitriou G; Mathews WB; Ravert HT; Musachio J; McCann UD; Ricaurte GA
    J Neurosci; 1998 Jan; 18(1):419-27. PubMed ID: 9412518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. There is a limited critical period for dopamine's effects on D1 receptor expression in the developing rat neostriatum.
    Thomas WS; Neal-Beliveau BS; Joyce JN
    Brain Res Dev Brain Res; 1998 Nov; 111(1):99-106. PubMed ID: 9804909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex.
    Goldstein RZ; Volkow ND
    Am J Psychiatry; 2002 Oct; 159(10):1642-52. PubMed ID: 12359667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging dopamine's role in drug abuse and addiction.
    Volkow ND; Fowler JS; Wang GJ; Baler R; Telang F
    Neuropharmacology; 2009; 56 Suppl 1(Suppl 1):3-8. PubMed ID: 18617195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associated alterations of striatal dopamine D2/D3 receptor and transporter binding in drug-naive patients with schizophrenia: a dual-isotope SPECT study.
    Yang YK; Yu L; Yeh TL; Chiu NT; Chen PS; Lee IH;
    Am J Psychiatry; 2004 Aug; 161(8):1496-8. PubMed ID: 15285982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinergic neuronal modulation alters dopamine D2 receptor availability in vivo by regulating receptor affinity induced by facilitated synaptic dopamine turnover: positron emission tomography studies with microdialysis in the conscious monkey brain.
    Tsukada H; Harada N; Nishiyama S; Ohba H; Kakiuchi T
    J Neurosci; 2000 Sep; 20(18):7067-73. PubMed ID: 10995853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications.
    Volkow ND; Wang GJ; Fowler JS; Logan J; Franceschi D; Maynard L; Ding YS; Gatley SJ; Gifford A; Zhu W; Swanson JM
    Synapse; 2002 Mar; 43(3):181-7. PubMed ID: 11793423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain dopaminergic system changes in drug addiction: a review of positron emission tomography findings.
    Hou H; Wang C; Jia S; Hu S; Tian M
    Neurosci Bull; 2014 Oct; 30(5):765-76. PubMed ID: 25260796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.